Alpine Woods Capital Investors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$347K Sell
699
-17
-2% -$7.53K 0.08% 149
2026
Q1
$320K Sell
716
-686
-49% -$320K 0.08% 132
2025
Q4
$636K Sell
1,402
-3,019
-68% -$1.3M 0.15% 116
2025
Q3
$1.73M Sell
4,421
-1,173
-21% -$490K 0.4% 75
2025
Q2
$2.49M Buy
5,594
+9
+0.2% +$4.15K 0.59% 58
2025
Q1
$2.71M Buy
5,585
+3,255
+140% +$1.52M 0.68% 54
2024
Q4
$938K Sell
2,330
-2,000
-46% -$927K 0.18% 112
2024
Q3
$2.17M Sell
4,330
-1,203
-22% -$578K 0.38% 80
2024
Q2
$2.59M Buy
5,533
+140
+3% +$60.8K 0.4% 80
2024
Q1
$2.12M Sell
5,393
-2,047
-28% -$865K 0.42% 83
2023
Q4
$3.03M Buy
7,440
+996
+15% +$368K 0.45% 69
2023
Q3
$2.24M Buy
6,444
+548
+9% +$192K 0.36% 89
2023
Q2
$2.08M Buy
5,896
+1,018
+21% +$343K 0.32% 88
2023
Q1
$1.54M Sell
4,878
-185
-4% -$55.5K 0.23% 111
2022
Q4
$1.46M Buy
5,063
+383
+8% +$117K 0.21% 107
2022
Q3
$1.35M Buy
4,680
+493
+12% +$142K 0.18% 117
2022
Q2
$1.18M Sell
4,187
-245
-6% -$65.6K 0.15% 126
2022
Q1
$1.16M Buy
4,432
+227
+5% +$53.9K 0.12% 136
2021
Q4
$923K Buy
4,205
+1,001
+31% +$195K 0.09% 147
2021
Q3
$581K Buy
3,204
+310
+11% +$60.5K 0.06% 175
2021
Q2
$584K Buy
2,894
+110
+4% +$23K 0.06% 175
2021
Q1
$598K Buy
2,784
+3
+0.1% +$659 0.07% 178
2020
Q4
$657K Buy
2,781
+1,855
+200% +$426K 0.08% 170
2020
Q3
$252K Buy
+926
New +$255K 0.04% 219

Other funds holding VRTX

Alpine Woods Capital Investors's VRTX Position: Q2 2026 in Review

Alpine Woods Capital Investors reduced its Vertex Pharmaceuticals (VRTX) stake by 2.4% in Q2 2026, selling an estimated $7.53K and leaving 699 shares worth $347K. The position accounts for 0.08% of the portfolio, ranked #149.

Alpine Woods Capital Investors first reported a position in VRTX in Q3 2020 and has held it in 24 quarters since. The position peaked at $3.03M in Q4 2023. 1,014 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Alpine Woods Capital Investors held 699 shares of Vertex Pharmaceuticals worth $347K as of Q2 2026.
  • Alpine Woods Capital Investors sold 17 Vertex Pharmaceuticals shares in Q2 2026, an estimated $7.53K.
  • Vertex Pharmaceuticals made up 0.08% of Alpine Woods Capital Investors's portfolio in Q2 2026, its #149 holding.
  • Alpine Woods Capital Investors first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
  • Alpine Woods Capital Investors's Vertex Pharmaceuticals position peaked at $3.03M in Q4 2023.
  • 1,014 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Alpine Woods Capital Investors's 13F filing for Q2 2026, filed 7 Aug 2026.